Motus GI Holdings, Inc. is a medical technology company. It has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques.
Its system consists of a workstation controller and a single-use, disposable Flex-Channel that attaches to most gastroscopes and colonoscopes (endoscopes). Together with the endoscopes, the Pure-Vu System performs intra-procedural cleaning. The Flex-Channel has an umbilical section that connects the disposable to the workstation.
The workstation delivers an irrigation medium of air and water that creates a pulsed vortex inside the GI tract to break up debris while simultaneously evacuating the content into waste receptacles..
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 85.0K | 
| Three Month Average Volume | 3.5M | 
| High Low | |
| Fifty-Two Week High | 10.05 USD | 
| Fifty-Two Week Low | 0.015 USD | 
| Fifty-Two Week High Date | 24 Oct 2023 | 
| Fifty-Two Week Low Date | 08 Aug 2024 | 
| Price and Volume | |
| Current Price | 0.0331 USD | 
| Beta | 2 | 
| Relative Price Change | |
| Four Week Relative Price Change | -42.68% | 
| Thirteen Week Relative Price Change | -82.82% | 
| Twenty-Six Week Relative Price Change | -95.57% | 
| Fifty-Two Week Relative Price Change | -99.65% | 
| Year-to-Date Relative Price Change | -97.81% | 
| Price Change | |
| One Day Price Change | -2.65% | 
| Thirteen Week Price Change | -81.61% | 
| Twenty-Six Week Price Change | -95.13% | 
| Five Day Price Change | -8.06% | 
| Fifty-Two Week Price Change | -99.57% | 
| Year-to-Date Price Change | -97.40% | 
| Month-to-Date Price Change | -52.71% | 
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 1.73687 USD | 
| Book Value Per Share (Most Recent Quarter) | 0.58858 USD | 
| Tangible Book Value Per Share (Last Fiscal Year) | 1.73687 USD | 
| Tangible Book Value Per Share (Most Recent Quarter) | 0.58858 USD | 
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -3.17251 USD | 
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.39407 USD | 
| Revenue Per Share (Trailing Twelve Months) | 0.11344 USD | 
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD | 
| Dividend Per Share (Trailing Twelve Months) | 0 USD | 
| Dividend Per Share (5 Year) | -99999.99 USD | 
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -15.89488 USD | 
| Excluding Extraordinary Items (Trailing Twelve Months) | -12.68056 USD | 
| Normalized (Last Fiscal Year) | -15.54405 USD | 
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -15.89488 USD | 
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -12.68056 USD | 
| Including Extraordinary Items (Last Fiscal Year) | -15.89488 USD | 
| Including Extraordinary Items (Trailing Twelve Months) | -12.68056 USD | 
| Cash | |
| Cash Per Share (Last Fiscal Year) | 3.20483 USD | 
| Cash Per Share (Most Recent Quarter) | 0.94878 USD | 
| Cash Flow Per Share (Last Fiscal Year) | -15.33767 USD | 
| Cash Flow Per Share (Trailing Twelve Months) | -3.52636 USD | 
| Free Cash Flow Per Share (Trailing Twelve Months) | -2.94182 USD | 
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -5,398 | 
| Cash Flow Revenue (Trailing Twelve Months) | -2,593 | 
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -3,239.76% | 
| Pretax Margin (Last Fiscal Year) | -4,033.54% | 
| Pretax Margin (5 Year) | -6,160.58% | 
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | -78.37% | 
| Gross Margin (Trailing Twelve Months) | -24.46% | 
| Gross Margin (5 Year) | -44.53% | 
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -3,821.63% | 
| Operating Margin (Trailing Twelve Months) | -3,014.68% | 
| Operating Margin (5 Year) | -6,017.65% | 
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -4,033.54% | 
| Net Profit Margin (Trailing Twelve Months) | -3,239.76% | 
| Net Profit Margin (5 Year) | -6,160.58% | 
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -63.25% | 
| Tangible Book Value (5 Year) | -32.03% | 
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% | 
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 14.29% | 
| Revenue Growth (3 Year) | 54.70% | 
| Revenue Change (Trailing Twelve Months) | -47.93% | 
| Revenue Per Share Growth | -11.19% | 
| Revenue Growth (5 Year) | 48.20% | 
| Capital Spending Debt | |
| Capital Spending (5 Year) | -28.25% | 
| Total Debt (5 Year) | -99,999.99% | 
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% | 
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 93.59% | 
| EPS Change (Trailing Twelve Months) | 83.94% | 
| EPS Growth (3 Year) | -99,999.99% | 
| EPS Growth (5 Year) | -99,999.99% | 
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% | 
| EBITDA (5 Year Interim) | -99,999.99% | 
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% | 
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 0 | 
| Price to Tangible Book (Most Recent Quarter) | 0 | 
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 | 
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 | 
| Net Debt | |
| Net Debt (Most Recent Quarter) | -2,643,000 | 
| Net Debt (Last Fiscal Year) | -2,686,000 | 
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 1 | 
| Price to Sales (Trailing Twelve Months) | 1 | 
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 | 
| PE Normalized (Last Fiscal Year) | -100,000 | 
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 | 
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 | 
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 | 
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 | 
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% | 
| Dividend Yield | -99,999.99% | 
| Current Dividend Yield | 0.00% | 
| Price to Book | |
| Price to Book (Last Fiscal Year) | 0 | 
| Price to Book (Most Recent Quarter) | 0 | 
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 46 | 
| Long Term Debt to Equity (Most Recent Quarter) | 22 | 
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% | 
| Payout Ratio (Trailing Twelve Months) | -99,999.99% | 
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 2 | 
| Quick Ratio (Most Recent Quarter) | 2 | 
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 | 
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 | 
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 2 | 
| Current Ratio (Most Recent Quarter) | 2 | 
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -11,298,000 | 
| Free Cash Flow (Trailing Twelve Months) | -8,480,000 | 
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -18 | 
| Net Interest Coverage (Trailing Twelve Months) | -13 | 
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 85 | 
| Total Debt to Equity (Most Recent Quarter) | 75 | 
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -103.47% | 
| Return on Assets (Trailing Twelve Months) | -109.80% | 
| Return on Assets (5 Year) | -80.63% | 
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -454.34% | 
| Return on Equity (Trailing Twelve Months) | -1,624.82% | 
| Return on Equity (5 Year) | -187.28% | 
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -153.17% | 
| Return on Investment (Trailing Twelve Months) | -182.50% | 
| Return on Investment (5 Year) | -112.32% |